In support of the prognostic relevance of nuclear Src in human tumors, Campbell and coauthors demonstrated that phosphorylated Src in the nucleus is also associated with improved patient outcome in estrogen receptor-positive tamoxifen-treated breast cancer [87]. The gene discussed is SRC; the disease is breast carcinoma.